DESCRIPTION OF PROBLEM
Antibiotics have been used for many yr in animal production [1] . Antibiotics are included in animal feeds to improve growth rate and feed efficiency, for disease prophylaxis, and disease therapy [2] . Even though antibiotics have been used by growers as effective supplements, the European Union banned the use of 4 growth promoting antibiotics (spiramycin, tylosin, bacitracin, and virginiamycin) [3] . The reason for this ban is that potential human pathogens found 1 Corresponding author: mn907763@dal.ca on processed poultry carcasses have become increasingly resistant to certain antibiotics [4] . Therefore, it is important to utilize improved biosecurity [5] or alternative dietary supplements including probiotics, prebiotics, and herbs as ways to grow broiler chickens without antibiotics [6, 7, 8] .
Lysozyme is 1, 4-β-N-acetylmuramidase. This enzyme cleaves the glycosidic bond between the N-acetylmuramic acid and Nacetylglucosamine in Gram-positive bacterial peptidoglycan of the cell wall [9] . Lysozyme, a common enzyme, is commercially extracted from avian egg white and is widespread in many tissues and secretions of animals [10] . Some studies have reported significant function of lysozyme in various organisms as a barrier against potential pathogenic bacteria [11, 12] . Lysozymes play a role as an antibacterial agent, which is mediated through its direct bacteriolytic action or by stimulating macrophage phagocytic function [11, 13] .
Research regarding the use of lysozyme as an alternative to antibiotics for poultry is limited. An in vitro experiment conducted by Zhang et al. [14] suggested that 200 ppm of lysozyme inhibited the growth of Clostridium perfringens and the production of α-toxin, which causes the lesions associated with necrotic enteritis in chickens. Some in vivo studies have shown lysozyme could potentially eliminate C. perfringens and improve growth performance in broiler chickens [15, 16] . Furthermore, lysozyme combined with EDTA has been shown to lyse Gram-negative bacteria [17] . Compared to the price of virginiamycin at 250 ppm ($3 per tonne of feed), lysozyme with EDTA at 100 ppm costs more ($4 per tonne of feed) [18] . Adding lysozyme with EDTA in only the critical periods of the growth cycle of broiler chickens could be the most effective way to utilize this ingredient. The current trial was designed to determine what these critical periods are by incorporating lysozyme with EDTA in several phases of the broiler production cycle. Additionally, a second trial was conducted to evaluate the benefits of providing lysozyme plus EDTA to broilers in sub-optimal housing conditions in order to determine the impact of this feed ingredient on growth performance and microbiota populations in a challenging environment.
MATERIALS AND METHODS

New Litter Trial
Animal Housing In the new litter trial, 2,240 male Ross 308 broiler chickens [19] [18] . For the other 4 treatments, the diet with 100 ppm lysozyme was fed during specific periods of the growth cycle of broiler chickens (d zero to 4 5 to 14, 15 to 24, or 25 to 35). Control diets were fed to the birds for the remaining period of the trial for each of these treatments.
Growth Performance
Birds were mass weighed per pen on d zero, 4, 14, 24, and 35. The feed remaining in the feeders was weighed on each weigh d and as mortality occurred. Performance was determined by measuring body weight, body weight gain, feed consumption, and feed conversion ratio (FCR).
Intestinal Microbiota
Two birds per pen were euthanized by cervical dislocation on d 4, 14, 24, and 35. Approximately 15 cm of the ileum one cm anterior to the ileal cecal junction was aseptically harvested, placed in sterile plastic bags on ice, and taken to the Level II microbiology laboratory. All samples were stored in a freezer at −80 • C until analyses of microbiota. The excised ileal sections were transferred to filtered stomacher bags and buffered peptone water was added in a 1:10 ratio. The samples were blended in the stomacher [24] for 100 s to ensure homogeneity. The numbers of total aerobic and anaerobic bacteria were enumerated using the method of AOAC 990.12 [25] . Lactic acid bacteria were determined using the same method except culturing with de Man, Rogosa, and Sharpe (MRS) agar. The numbers of coliform/E. coli were measured using the method of AOAC 989.10 [25] . Following the methodology described by Bolder et al. [26] , the numbers of C. perfringens colonies were counted.
Statistical Analysis
For growth performance parameters, the trial was a completely randomized block design with period of time in which the lysozyme or antibiotic was fed to the birds as the main factor and room as the block. The pen was considered as the experimental unit. Data were analyzed by ANOVA in SAS 9.4 [27, 28] . Growth data were analyzed as repeated measures with age of birds as a factor. Where interactions with treatment and age of birds were significant (α = 0.05), data was sliced by age and analyzed separately. If significant main effects or interactions were found, the Tukey-Kramer method was used to compare differences among the least-square means [29] . For the bacterial, the same design was used except the data were not analyzed as repeated measures.
Used Litter Trial
In the used litter trial, 2,184 male Ross 308 broilers [19] (Table 2) [21]. Dietary treatments provided to the birds and the data collection and analysis of growth performance and intestinal microbiota followed the same procedure as in the new litter trial.
RESULTS AND DISCUSSION
Growth Performance
The inclusion of antibiotic or lysozyme in the broiler diets at different periods during growth had no effects (P > 0.05) on daily weight gain, feed consumption or FCR on both of the new litter and used litter trials (Table 3 and Table 4 ). For each period (d zero to 4, 5 to 14, 15 to 24, and 25 to 35), all the growth parameters were not affected by the inclusion of antibiotic or lysozyme (P > 0.05).
The new litter trial failed to demonstrate a benefit to growth performance for either virginiamycin or lysozyme. However, other researchers have reported that the inclusion of lysozyme or virginiamycin in the diets of poultry can influence production parameters [30, 31, 32, 33, 34, 35] .
The reason lysozyme and virginiamycin did not affect growth performance might be that the new litter bedding provided effective biosecurity during this trial and, therefore, reduced the likelihood that the chickens would be challenged by bacteria in the environment [5] . When broilers are not under an environmental stress, dietary antibiotics or alternative antimicrobials may not improve growth performance. The used litter from a previous broiler flock was more likely to contain bacteria from the previous flock of broilers, which could pose a potential challenge for the incoming chicks [36] . The lack of a difference between the negative control birds (no antibiotic) and the birds given antibiotic indicated that use of 50% reused litter was not enough of a challenge to restrict growth or affect the health of these birds (P > 0.05).
Intestinal Micorbiota
In the new litter trial, the number of aerobic bacteria, anaerobic bacteria, coliforms, E. coli, lactic acid bacteria, and C. perfringens in the ileum was not influenced (P > 0.05) by the inclusion of the antibiotic or lysozyme in the diets (Table 5 ). Processing and supplementation of other feed ingredients can strengthen the antimicrobial function. EDTA acts synergistically with lysozyme against bacteria, such as Listeria monocytogene [37] . The combination of lysozyme and EDTA has suppressed the growth of L. monocytogenes, and inhibited other microbiota to prevent meat spoilage [38] . The antibacterial action of lysozyme might be improved by other methods. The combination of lysozyme with other supplements such as nisin improved overall antibacterial activity [39] . Results obtained with lysozyme with EDTA in vitro could not be the same in an in vivo situation. In the current study, lysozyme mixed with EDTA in a ratio of 1:4, had no detectable effect on [5] . The E. coli numbers in the ileal samples of the birds fed lysozyme for the duration of the trial as well as during days 5 to 14 were lower (P < 0.05) than the E. coli number from those fed the antibiotic for the duration of the trial (Table 6 ). Before transformation of the data to log 10 basis, the numbers of E. coli in the ileum when birds were fed antibiotic, lysozyme, and lysozyme only on d 5 to 14 were 9.3 × 10 4 , 1.9 × 10 4 , and 1.7 × 10 4 cfu g −1 , respectively. Lysozyme added in the diet reduced the numbers of E. coli by more than 80% in the ileum compared to antibiotic fed birds.
CONCLUSIONS AND APPLICATIONS
1. When testing whether antimicrobials have an effect, appropriate environmental challenge such as housing birds with dirty litter could be needed to provide stress to birds. 2. For the trial in which used litter was provided, feeding 100 ppm lysozyme to birds from d 5 to 14 during the starter period and throughout the trial reduced the number of E. coli in the ileum compared with feeding the antibiotic to the birds. 3. Since lysozyme can change intestinal microbiota, this study provides valuable information on potential possibility of lysozyme as an alternative to antibiotic.
